Anondita Medicare Ltd Auditor Reports

The Board of Directors

ANONDITA MEDICARE LIMITED

Flat No.704 Narmada Blk, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, India, 110070

Dear Sirs,

1. We have examined the attached Restated Standalone Financial Information of ANONDITA MEDICARE LIMITED (the "Company" or the "Issuer") for the year ending March 31, 2025 comprising the Restated Standalone Statement of Assets and Liabilities as at March 31, 2025, the Restated Standalone Statements of Profit and Loss, the Restated Standalone Statements of Cash Flows for the year then ended, the Summary Statement of significant Accounting Policies, and other explanatory information (collectively, the "Restated Standalone Financial Information of the company") We have also examined the Restated Statement of Assets and Liabilities as at March 31, 2024 and 2023, the Restated Statements of Profit and Loss, the Restated Statements of Cash Flows for the years ended March 31, 2024 and 2023 of Anondita Healthcare (erstwhile proprietorship concern acquired through business acquisition agreement dated April 01, 2024), the Summary Statement of significant Accounting Policies, and other explanatory information (collectively, the "Restated Financial Information of the proprietorship concern"), as approved by the Board of Directors of the Company at their meeting held on 08-08-2025 for the purpose of inclusion in the Red Herring Prospectus ("RHP") prepared by the Company in connection with its proposed Initial Public Offer of equity shares ("IPO") prepared in terms of the requirements of:

a) Section 26 of Part I of Chapter III of the Companies Act, 2013, as amended (the "Act");

b) The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ("ICDR Regulations"); and

c) The Guidance Note on Reports in Company Prospectuses (Revised 2019) issued by the Institute of Chartered Accountants of India ("ICAI"), as amended (the "Guidance Note").

2. The Companys Board of Directors is responsible for the preparation of the Restated

Standalone Financial Information of the company and the Restated Financial Information of the proprietorship concern for the purpose of inclusion in the RHP to be filed with Securities and Exchange Board of India (SEBI) and Registrar of Companies, Delhi ("RoC") in connection with the proposed IPO. The Restated Standalone Financial Information of the company and the Restated Financial Information of the proprietorship concern have been prepared by the management of the Company on the basis of preparation stated in Annexure 1 to the Restated Standalone Financial Information of the company and the proprietorship concern. The Board of Directors of the company are responsible for designing, implementing and maintaining adequate internal control relevant to the preparation and presentation of the restated financial information of the company. The Board of Directors are also responsible for identifying and ensuring that the company comply with the Act, ICDR Regulations and the Guidance Note.

3. We have examined such Restated Standalone Financial Information of the company and the proprietorship concern taking into consideration:

a) The terms of reference and terms of our engagement agreed upon with you in accordance with our engagement letter dated 14-10-2024 in connection with the proposed IPO of equity shares of the Issuer;

b) The Guidance Note. The Guidance Note also requires that we comply with the ethical requirements of the Code of Ethics issued by the ICAI;

c) Concepts of test checks and materiality to obtain reasonable assurance based on verification of evidence supporting the Restated Standalone Financial Information; and

d) The requirements of Section 26 of the Act and the ICDR Regulations. Our work was performed solely to assist you in meeting your responsibilities in relation to your compliance with the Act, the ICDR Regulations and the Guidance Note in connection with the IPO.

4. These Restated Standalone Financial Information of the company and the proprietorship concern have been compiled by the management from:

a) the audited standalone financial statements of the company as at March 31, 2025 prepared in accordance with Indian GAAP as prescribed under Section 133 of the Act and other accounting principles generally accepted in India, which have been approved by the Board of Directors at their meeting held on 28-11-2024.

b) the audited standalone financial statements of the proprietorship concern as at March 31, 2024 and 2023 have been prepared in accordance with Indian GAAP and other accounting principles generally accepted in India,

5. For the purpose of our examination, we have relied on Auditors reports issued by us on the standalone financial statements of the company as at March 31, 2025 and for the financial statements of the proprietorship concern, for the years ended March 31, 2024 and 2023 as referred in Paragraph 4 above.

6. In accordance with the requirements of Section 26 of Part I of Chapter III of Act including rules made there under, ICDR Regulations, Guidance Note and Engagement Letter, we report that-

a) The "Restated Standalone Statement of Assets and Liabilities" of the Company as at March 31, 2025 and Restated financial statements of proprietorship concern, for the years ended March 31, 2024 and 2023 is prepared by the Company and approved by the Board of Directors. These Restated Standalone Statement of Assets and Liabilities, have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company, as in our opinion were appropriate and more fully described in Significant Accounting Policies as set out in Annexure 1 to this Report.

b) The "Restated Standalone Statement of Profit and Loss" of the Company for Financial year ended March 31, 2025 and Restated Statement of Profit and Loss of the proprietorship concern for the year ended March 31, 2024 and March 31, 2023 is prepared by the Company and approved by the Board of Directors. These Restated Standalone Statement of Profit and Loss have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company and proprietorship concern, as in our opinion were appropriate and more fully described in Significant Accounting Policies as set out in Annexure 1 to this Report.

c) The "Restated Standalone Statement of Cash Flow" of the Company for Financial year ended March 31, 2025 and Restated Statement of Cash Flow of the proprietorship concern for the year ended March 31, 2024 and March 31, 2023 is prepared by the Company and approved by the Board of Directors. These Statements of Cash Flow, as restated have been arrived at after making such adjustments and regroupings to the individual financial statements of the Company and proprietorship concern, as in our opinion were appropriate and more fully described in Significant Accounting Policies as set out in Note 1 to this Report.

We have also examined the following other financial information relating to the Company and the proprietorship concern prepared by the Management and as approved by the Board of Directors of the Company and annexed to this report relating to the Company for Financial year ended March 31, 2025 and for the year ended March 31, 2024 and March 31, 2023 of the proprietorship concern proposed to be included in the RHP for the proposed IPO.

In our opinion and to the best of information and explanation provided to us, the Restated Standalone Financial Statement of the Company and the proprietorship concern, read with significant accounting policies as appearing in Annexure 1 are prepared after providing appropriate adjustments and regroupings as considered appropriate.

Emphasis of Matters

1. The company is in the process of getting transferred the following properties in the name of the company: a. Residential Property at Flat No 704, Narmada BLK-6 PKT-6 Sec-D, Vasant Kunj, New Delhi-110070 b. Property at Plot No. H-437, KhushKhera, Industrial Area, Rajsthan-301019.

2. In respect of share in partnership firm necessary documents are still pending for giving effect to the transfer of the same in the name of the company.

3. The company is in the process of getting transferred the following as on March 31, 2025: a. Borrowings other than working capital & working capital loan availed from Deutsch bank and the borrowings of 292 lakhs from IDFC Bank Ltd (Co-borrower, Anondita Medicare Ltd are in the name of acquiree entity Anondita Healthcare (Proprietorship concern); b. Fixed Deposit of Rs 1,24,95,926/- held by the company is in the name of acquiree entity Anondita Healthcare (Proprietorship concern); c. All Vehicles are in the name of acquiree entity Anondita Healthcare (Proprietorship concern)

Our opinion is not modified in respect of above matters.

We, M/s. Jain Chopra and Company, Chartered Accountants have been subjected to the peer review process of the Institute of Chartered Accountants of India (ICAI) and our peer Review Certificate is valid as on the date of signing of this report.

The preparation and presentation of the Financial Statements referred to above are based on the Audited financial statements of the Company and the proprietorship concern in accordance with the provisions of the Act and ICDR Regulations. The Financial Statements and information referred to above is the responsibility of the management of the Company.

The report should not in any way be construed as a re-issuance or re-dating of any of the previous audit reports nor should this report be construed as a new opinion on any of the financial statements referred to therein.

We have no responsibility to update our report for events and circumstances occurring after the date of the report.

In our opinion, the above Standalone Financial Statements along with Annexures 2 to 42 of this report read with the respective Significant Accounting Polices as set out in Annexure 1 are prepared after making adjustments and regrouping as considered appropriate and have been prepared in accordance with the Companies Act, ICDR Regulations, Engagement Letter and Guidance Note issued by ICAI.

Our report is intended solely for use of the management and for inclusion in the DRHP in connection with the Proposed SME IPO of Equity Shares of the Company and our report should not be used, referred to or distributed for any other purpose without our prior consent in writing.

FRN: 002198N

Peer Review Certificate No.-015091

Partner

M.No. 501860

Place: New Delhi